Indiana Governor Mike Braun today joined Eli Lilly and Company to celebrate a major expansion at the company’s Lebanon campus, including the opening of Lilly Lebanon Advanced Therapies – its first dedicated genetic medicine manufacturing facility – and additional investments across its Indiana operations.
Lilly’s latest commitment brings its total planned capital investments in Indiana to more than $21 billion since 2020, further solidifying the state’s position as a global leader in life sciences, advanced manufacturing and innovation. This builds on Gov. Braun’s recent announcement of a $1 billion, 10-year life sciences initiative focused on creating 100,000 new jobs within plant, animal and human health.
“This expansion reflects the strength of a long-standing partnership between Lilly and the state of Indiana – one that continues to deliver real results for Hoosiers,” said Gov. Braun. “With this investment in Lebanon and across the state, Indiana is reinforcing its position as a prime destination for life sciences and advanced manufacturing, spanning innovation, production and global distribution. Together, we are helping lead the future of medicine while creating high-quality jobs and new opportunities for our communities.”
The Lebanon site, located within the state’s LEAP Innovation District, plays a central role in Indiana’s strategy to grow next-generation industries and attract transformational investment. Lilly Lebanon Advanced Therapies will support both clinical and commercial production of advanced medicines, including genetic therapies designed to address disease at its source.
“Lilly’s legacy of firsts in Indiana continues today—and the best measure of that legacy is what we do next,” said David A. Ricks, Lilly chair and CEO. “From genetic medicines that could one day prevent disease at its source, to Foundayo, a pill making weight loss treatment accessible to millions, we are not just discovering the medicines of the future—we are building the world’s most advanced plants to make them. When our Lebanon API site opens in 2027, it will be the largest API production site in U.S. history, a commitment we chose to build here, at home.”
Lilly’s expansion in Lebanon also builds on its broader footprint across the state, where the company employs thousands of Hoosiers and continues to invest in research, development and manufacturing capabilities. The company’s presence contributes significantly to Indiana’s economy, supporting jobs, driving innovation and strengthening the state’s leadership in the global life sciences sector.
Indiana’s life sciences industry is one of the largest and fastest growing in the nation, supported by a robust network of research institutions, industry partners and workforce development initiatives. The state continues to rank among the top exporters of life sciences products in the U.S. and remains committed to advancing the sector through strategic investments and partnerships.
Today’s announcement further positions Indiana and the central Indiana region as a hub for advanced manufacturing and next-generation technologies, ensuring the state remains competitive in attracting future investment and supporting long-term economic growth